Regulus Therapeutics Inc. (NASDAQ: RGLS) Stock Information | RedChip

Regulus Therapeutics Inc. (NASDAQ: RGLS) Listen to this Section


$1.60
+0.0100 ( +0.63% ) 139.7K

Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.

Market Data


Open


$1.60

Previous close


$1.59

Volume


139.7K

Market cap


$105.40M

Day range


$1.56 - $1.64

52 week range


$1.08 - $3.79

Insider Ownership Transactions

Total Amount Purchased: -2,639,000.00 | $ -4,222,400.00

Date Type Amount Purchased Purchaser
2024-07-29 Buy 4000.00 Collier Kathryn J
2024-05-21 Sale -990000.00 Hagan Joseph P
2024-05-21 Sale -363000.00 Aker Christopher Ray
2024-05-21 Sale -60000.00 Huang Alice Shih-hou
2024-05-21 Sale -60000.00 Witz Pascale
2024-05-21 Sale -60000.00 Nunn Jason Raleigh
2024-05-21 Sale -60000.00 BALTIMORE DAVID
2024-05-21 Sale -60000.00 Rosen Hugh
2024-05-21 Sale -528000.00 Klassen Preston
2024-05-21 Sale -462000.00 CALSADA CRISPINA

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 52 Aug 08, 2024
8-k 8K-related 15 Aug 08, 2024
4 Insider transactions 1 Jul 29, 2024
8-k 8K-related 13 Jun 24, 2024
4 Insider transactions 1 May 21, 2024
4 Insider transactions 1 May 21, 2024
4 Insider transactions 1 May 21, 2024
4 Insider transactions 1 May 21, 2024
4 Insider transactions 1 May 21, 2024
4 Insider transactions 1 May 21, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.